Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Clinical trial NCT00993486 · COMPLETED

Trial details

NCT number: NCT00993486
Sponsor: Kiadis Pharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematologic Diseases Hematologic Malignancies

Start date: 2005-01-01
Primary completion: 2008-10-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.